- Home
- RAND vs ATRA Comparison
RAND vs ATRA Comparison
Compare RAND & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RAND | ATRA |
|---|---|---|
| Founded | 1969 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.4M | 38.9M |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | RAND | ATRA |
|---|---|---|
| Price | $11.98 | $5.18 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 4.1K | ★ 140.3K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | ★ 9.59% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.93 |
| Revenue | N/A | ★ $128,940,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.71 |
| Revenue Growth | N/A | ★ 1404.02 |
| 52 Week Low | $10.05 | $3.92 |
| 52 Week High | $26.00 | $19.15 |
Technical Indicators
Market Signals| Indicator | RAND | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 54.43 | 44.48 |
| Support Level | $10.56 | $4.06 |
| Resistance Level | $12.50 | $5.80 |
| Average True Range (ATR) | 0.42 | 0.53 |
| MACD | 0.13 | 0.31 |
| Stochastic Oscillator | 73.68 | 61.24 |
Price Performance
Historical ComparisonAbout RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).